SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-010781
Filing Date
2019-08-14
Accepted
2019-08-14 17:28:20
Documents
56
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20190630.htm   iXBRL 10-Q 1112846
2 EXHIBIT-31.1 a2019q2-exhibit311.htm EX-31.1 16452
3 EXHIBIT-31.2 a2019q2-exhibit312.htm EX-31.2 16461
4 EXHIBIT-32.1 a2019q2-exhibit321.htm EX-32.1 9170
  Complete submission text file 0001628280-19-010781.txt   4492472

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20190630.xsd EX-101.SCH 32369
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20190630_cal.xml EX-101.CAL 67962
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20190630_def.xml EX-101.DEF 121853
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20190630_lab.xml EX-101.LAB 380171
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20190630_pre.xml EX-101.PRE 243785
10 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20190630_htm.xml XML 700724
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 191027744
SIC: 2834 Pharmaceutical Preparations